The antiproliferative effects of DHEA in MCF-7 breast cancer cells are mediated by the activation of the PPARγ, a nuclear receptor involved in several diseases, such as inflammation, metabolic disorders, cardiovascular disease, and different types of cancer [83,84]. Here, PPARG is linked to breast cancer.